With the aim to analyze the contribution of NAD+ signaling in cancer cells, this study has revealed that PARP16 supports the ADPr of ribosomal protein utilizing NAD+ synthesized in the cytoplasm by NAMNT-2, whose protein level is upregulated here. The gene discussed is PARP16; the disease is cancer.